- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
- Web-based presentations from experts
- Free for all to participate
- First-hand information on nanotechnology
On January 25, 2012, Prof. Wolfgang Heckl will inaugurate Nanostart AG's NanoWebTalk series with a live web-based presentation (in German) entitled "Nanotechnology Between Hype and Hope". Anyone can participate in the event from the comfort of their computer.
Prof. Heckl is the General Director of the German Museum, a member of Nanostart's Supervisory Board, and one of the world's leading scientists in the field of nanotechnology. His presentation marks the start of NanoWebTalk, a new event series organized by Nanostart AG.
NanoWebTalks are presentations on nanotechnology that will be held on the Internet every few weeks. Proven experts from the Nanostart network will discuss various topics relating to nanotechnology in online presentations, which will be followed by question-and-answer sessions. The events will generally begin at 5:00 p.m. CET.
Other speakers already lined up include the journalist and physicist Niels Boeing (February), Dr. Péter Krüger, Head of Bayer Working Group Nanotechnology (March), and Prof. Ralf Wehrspohn, Head of the Fraunhofer Institute for Mechanics of Materials (April).
Nanotechnology is considered to be the key technology of the 21st century. It facilitates innovative products and procedures that can change the world for the better and open up significant opportunities for industry and society. Trust and acceptance toward nanotechnology are essential for optimally exploiting the indisputable benefits and enormous potential it offers in terms of positive economic and social development. Nanostart AG promotes a nuanced, ideology-free approach and impartial, objective discussion. The NanoWebTalk series is intended to contribute to social discourse by providing first-hand information on nanotechnology.
More information on the NanoWebTalks, topics, dates and speakers can be found at www.nanowebtalk.de. Interested parties can also register for the events at this address.
About Nanostart AG
Nanostart AG (OTCQX: NASRY) headquartered in the German financial capital of Frankfurt, is a leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary Nanostart Asia and the venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government.
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.
For more information, please click here
Dr. Hans Joachim Duerr
Head of Corporate Communications
D-60313 Frankfurt, Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
Copyright © Nanostart AGIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Lehigh engineer discovers a high-speed nano-avalanche: New findings published in the Journal of Electrochemical Society about the process involving transformations in glass that occur under intense electrical and thermal conditions could lead the way to more energy-efficient glas August 24th, 2016
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016